Neogen EBITDA Margin 2012-2026 | NEOG
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Neogen (NEOG) over the last 10 years. The current EBITDA margin for Neogen as of May 31, 2026 is .
| Neogen EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2026-05-31 | $0.87B | $0.10B | 11.84% |
| 2026-02-28 | $0.87B | $0.09B | 10.11% |
| 2025-11-30 | $0.88B | $0.10B | 11.36% |
| 2025-08-31 | $0.89B | $0.12B | 13.32% |
| 2025-05-31 | $0.89B | $0.14B | 15.32% |
| 2025-02-28 | $0.91B | $0.16B | 17.77% |
| 2024-11-30 | $0.91B | $0.17B | 18.05% |
| 2024-08-31 | $0.91B | $0.17B | 18.51% |
| 2024-05-31 | $0.93B | $0.19B | 20.00% |
| 2024-02-29 | $0.93B | $0.19B | 20.65% |
| 2023-11-30 | $0.92B | $0.19B | 21.11% |
| 2023-08-31 | $0.92B | $0.17B | 18.28% |
| 2023-05-31 | $0.82B | $0.13B | 15.94% |
| 2023-02-28 | $0.72B | $0.10B | 13.89% |
| 2022-11-30 | $0.63B | $0.07B | 10.95% |
| 2022-08-31 | $0.53B | $0.07B | 12.62% |
| 2022-05-31 | $0.53B | $0.08B | 15.56% |
| 2022-02-28 | $0.51B | $0.08B | 16.34% |
| 2021-11-30 | $0.50B | $0.09B | 18.29% |
| 2021-08-31 | $0.49B | $0.10B | 20.12% |
| 2021-05-31 | $0.47B | $0.10B | 20.30% |
| 2021-02-28 | $0.45B | $0.09B | 20.89% |
| 2020-11-30 | $0.43B | $0.09B | 21.02% |
| 2020-08-31 | $0.43B | $0.09B | 21.13% |
| 2020-05-31 | $0.42B | $0.09B | 20.81% |
| 2020-02-29 | $0.42B | $0.09B | 20.29% |
| 2019-11-30 | $0.42B | $0.09B | 20.62% |
| 2019-08-31 | $0.42B | $0.09B | 20.67% |
| 2019-05-31 | $0.42B | $0.09B | 20.72% |
| 2019-02-28 | $0.41B | $0.09B | 21.07% |
| 2018-11-30 | $0.41B | $0.09B | 21.46% |
| 2018-08-31 | $0.40B | $0.09B | 21.53% |
| 2018-05-31 | $0.40B | $0.09B | 21.61% |
| 2018-02-28 | $0.39B | $0.09B | 22.02% |
| 2017-11-30 | $0.38B | $0.08B | 21.90% |
| 2017-08-31 | $0.37B | $0.08B | 21.95% |
| 2017-05-31 | $0.36B | $0.08B | 22.01% |
| 2017-02-28 | $0.35B | $0.08B | 21.25% |
| 2016-11-30 | $0.34B | $0.07B | 20.76% |
| 2016-08-31 | $0.33B | $0.07B | 20.85% |
| 2016-05-31 | $0.32B | $0.07B | 21.43% |
| 2016-02-29 | $0.31B | $0.07B | 21.54% |
| 2015-11-30 | $0.30B | $0.07B | 22.52% |
| 2015-08-31 | $0.29B | $0.07B | 22.76% |
| 2015-05-31 | $0.28B | $0.06B | 22.61% |
| 2015-02-28 | $0.27B | $0.06B | 22.51% |
| 2014-11-30 | $0.27B | $0.06B | 22.26% |
| 2014-08-31 | $0.26B | $0.06B | 21.40% |
| 2014-05-31 | $0.25B | $0.05B | 21.37% |
| 2014-02-28 | $0.24B | $0.05B | 21.52% |
| 2013-11-30 | $0.23B | $0.05B | 22.12% |
| 2013-08-31 | $0.22B | $0.05B | 23.04% |
| 2013-05-31 | $0.21B | $0.05B | 23.08% |
| 2013-02-28 | $0.20B | $0.05B | 22.89% |
| 2012-11-30 | $0.20B | $0.04B | 22.05% |
| 2012-08-31 | $0.19B | $0.04B | 21.69% |
| 2012-05-31 | $0.19B | $0.04B | 21.62% |
| 2012-02-29 | $0.18B | $0.04B | 22.22% |
| 2011-11-30 | $0.18B | $0.04B | 22.60% |
| 2011-08-31 | $0.18B | $0.04B | 23.30% |
| 2011-05-31 | $0.17B | $0.04B | 23.70% |
| 2011-02-28 | $0.17B | $0.04B | 23.21% |
| 2010-11-30 | $0.16B | $0.04B | 23.13% |
| 2010-08-31 | $0.15B | $0.03B | 22.52% |
| 2010-05-31 | $0.14B | $0.03B | 22.14% |
| 2010-02-28 | $0.13B | $0.03B | 21.97% |
| 2009-11-30 | $0.13B | $0.03B | 21.43% |
| 2009-08-31 | $0.12B | $0.03B | 21.31% |
| 2009-05-31 | $0.12B | $0.03B | 21.01% |
| 2009-02-28 | $0.12B | $0.03B | 21.74% |
| 2008-11-30 | $0.11B | $0.03B | 22.32% |
| 2008-08-31 | $0.11B | $0.02B | 22.22% |
| 2008-05-31 | $0.10B | $0.02B | 21.57% |
| 2008-02-29 | $0.10B | $0.02B | 20.41% |
| 2007-11-30 | $0.09B | $0.02B | 20.21% |
| 2007-08-31 | $0.09B | $0.02B | 19.10% |
| 2007-05-31 | $0.09B | $0.02B | 18.60% |
| 2007-02-28 | $0.08B | $0.02B | 19.28% |
| 2006-11-30 | $0.08B | $0.02B | 18.75% |
| 2006-08-31 | $0.08B | $0.01B | 18.42% |
| 2006-05-31 | $0.07B | $0.01B | 17.81% |
| 2006-02-28 | $0.07B | $0.01B | 14.49% |
| 2005-11-30 | $0.07B | $0.01B | 13.85% |
| 2005-08-31 | $0.06B | $0.01B | 14.06% |
| 2005-05-31 | $0.06B | $0.01B | 14.52% |
| 2005-02-28 | $0.06B | $0.01B | 16.39% |
| 2004-11-30 | $0.06B | $0.01B | 16.13% |
| 2004-08-31 | $0.06B | $0.01B | 17.24% |
| 2004-05-31 | $0.06B | $0.01B | 16.36% |
| 2004-02-29 | $0.05B | $0.01B | 16.98% |
| 2003-11-30 | $0.05B | $0.01B | 18.37% |
| 2003-08-31 | $0.05B | $0.01B | 16.33% |
| 2003-05-31 | $0.05B | $0.01B | 16.67% |
| 2003-02-28 | $0.05B | $0.01B | 17.02% |
| 2002-11-30 | $0.05B | $0.01B | 15.22% |
| 2002-08-31 | $0.04B | $0.01B | 15.91% |
| 2002-05-31 | $0.04B | $0.01B | 16.28% |
| 2002-02-28 | $0.04B | $0.01B | 17.50% |
| 2001-11-30 | $0.04B | $0.01B | 17.95% |
| 2001-08-31 | $0.04B | $0.01B | 18.92% |
| 2001-05-31 | $0.04B | $0.01B | 17.14% |
| 2001-02-28 | $0.03B | $0.01B | 15.63% |
| 2000-11-30 | $0.03B | $0.01B | 17.24% |
| 2000-08-31 | $0.03B | $0.00B | 12.00% |
| 2000-05-31 | $0.02B | $0.00B | 13.64% |
| 2000-02-29 | $0.02B | $0.00B | 9.52% |
| 1999-11-30 | $0.02B | $0.00B | 10.00% |
| 1999-08-31 | $0.02B | $0.00B | 14.29% |
| 1999-05-31 | $0.02B | $0.00B | 13.64% |
| 1999-02-28 | $0.02B | $0.01B | 36.36% |
| 1998-11-30 | $0.02B | $0.01B | 31.82% |
| 1998-08-31 | $0.02B | $0.01B | 42.86% |
| 1998-05-31 | $0.02B | $0.01B | 52.63% |
| 1998-02-28 | $0.02B | $0.01B | 38.89% |
| 1997-11-30 | $0.02B | $0.01B | 58.82% |
| 1997-08-31 | $0.02B | $0.01B | 43.75% |
| 1997-05-31 | $0.02B | $0.01B | 43.75% |
| 1997-02-28 | $0.02B | $0.01B | 46.67% |
| 1996-11-30 | $0.01B | $0.00B | 28.57% |
| 1996-08-31 | $0.01B | $0.00B | 30.77% |
| 1996-05-31 | $0.01B | $0.00B | 16.67% |
| 1996-02-29 | $0.01B | 0 | 0.00% |
| 1995-11-30 | $0.01B | 0 | 0.00% |
| 1995-08-31 | $0.01B | 0 | 0.00% |
| 1995-05-31 | $0.01B | 0 | 0.00% |
| 1995-02-28 | $0.01B | 0 | 0.00% |
| 1994-11-30 | $0.01B | 0 | 0.00% |
| 1994-08-31 | $0.01B | 0 | 0.00% |
| 1994-05-31 | $0.01B | 0 | 0.00% |
| 1994-02-28 | $0.01B | 0 | 0.00% |
| 1993-11-30 | $0.01B | 0 | 0.00% |
| 1993-08-31 | $0.01B | 0 | 0.00% |
| 1993-05-31 | $0.01B | 0 | 0.00% |
| 1993-02-28 | $0.01B | 0 | 0.00% |
| 1992-11-30 | $0.01B | 0 | 0.00% |
| 1992-08-31 | $0.01B | 0 | 0.00% |
| 1992-05-31 | $0.01B | 0 | 0.00% |
| 1992-02-29 | $0.01B | 0 | 0.00% |
| 1991-11-30 | $0.01B | 0 | 0.00% |
| 1991-08-31 | $0.01B | 0 | 0.00% |
| 1991-05-31 | $0.01B | $0.00B | -20.00% |
| 1991-02-28 | $0.01B | $0.00B | -20.00% |
| 1990-11-30 | $0.01B | $0.00B | -20.00% |
| 1990-08-31 | $0.01B | $0.00B | -16.67% |
| 1990-05-31 | $0.01B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.606B | $0.870B |
| Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $178.385B | 19.60 |
| Medtronic (MDT) | Ireland | $119.983B | 16.40 |
| Stryker (SYK) | United States | $108.118B | 20.21 |
| EssilorLuxottica (ESLOY) | France | $79.433B | 0.00 |
| Boston Scientific (BSX) | United States | $65.288B | 14.03 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.930B | 0.00 |
| Medline (MDLN) | United States | $42.846B | 0.00 |
| Agilent Technologies (A) | United States | $41.387B | 24.22 |
| ResMed (RMD) | United States | $32.167B | 19.96 |
| GE HealthCare Technologies (GEHC) | United States | $29.021B | 13.88 |
| Koninklijke Philips (PHG) | Netherlands | $24.651B | 13.13 |
| Terumo (TRUMY) | Japan | $21.625B | 20.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.414B | 11.38 |
| Baxter (BAX) | United States | $12.336B | 11.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.926B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.854B | 39.71 |
| Demant (WILYY) | Denmark | $9.592B | 0.00 |
| Insulet (PODD) | United States | $9.557B | 23.48 |
| Sunny Optical Technology (SNPTF) | China | $9.142B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.548B | 20.15 |
| Raia Drogasil SA - (RADLY) | $4.931B | 0.00 | |
| Haemonetics (HAE) | United States | $4.837B | 21.22 |
| BillionToOne (BLLN) | United States | $4.757B | 144.03 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| Envista Holdings (NVST) | United States | $4.142B | 17.54 |
| ICU Medical (ICUI) | United States | $3.939B | 23.52 |
| AtriCure (ATRC) | United States | $2.838B | 242.57 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| Curaleaf Holdings (CURLF) | United States | $2.356B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.256B | 10.77 |
| Trulieve Cannabis (TRLV) | United States | $2.238B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.207B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.894B | 5.46 |
| LeMaitre Vascular (LMAT) | United States | $1.847B | 29.69 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.736B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.733B | 221.44 |
| Phibro Animal Health (PAHC) | United States | $1.459B | 11.20 |
| Green Thumb Industries (GTBIF) | United States | $1.428B | 15.23 |
| Kestra Medical Technologies (KMTS) | United States | $1.410B | 0.00 |
| Omeros (OMER) | United States | $1.264B | 6.40 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.094B | 0.00 |
| CeriBell (CBLL) | United States | $0.934B | 0.00 |
| InMode (INMD) | Israel | $0.856B | 11.91 |
| AdaptHealth (AHCO) | United States | $0.802B | 16.80 |
| VAREX IMAGING (VREX) | United States | $0.777B | 17.09 |
| QuidelOrtho (QDEL) | United States | $0.763B | 8.24 |
| Glass House Brands (GLAS) | United States | $0.760B | 0.00 |
| Valneva SE (VALN) | France | $0.633B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.582B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.564B | 0.00 |
| Brainsway (BWAY) | Israel | $0.548B | 30.98 |
| Evolus (EOLS) | United States | $0.524B | 0.00 |
| Cerus (CERS) | United States | $0.514B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.512B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.438B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.422B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.373B | 0.00 |
| SNDL (SNDL) | Canada | $0.353B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.337B | 24.56 |
| Sanara MedTech (SMTI) | United States | $0.321B | 159.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.294B | 0.00 |
| MacroGenics (MGNX) | United States | $0.268B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 13.14 |
| High Tide (HITI) | Canada | $0.234B | 52.60 |
| OraSure Technologies (OSUR) | United States | $0.232B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.225B | 21.55 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.205B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.194B | 0.00 |
| Exagen (XGN) | United States | $0.178B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.155B | 0.00 |
| Organigram Global (OGI) | Canada | $0.152B | 0.00 |
| Apyx Medical (APYX) | United States | $0.127B | 0.00 |
| Quanterix (QTRX) | United States | $0.118B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| ImmuCell (ICCC) | United States | $0.088B | 121.38 |
| Accendra Health (ACH) | United States | $0.086B | 4.87 |
| FitLife Brands (FTLF) | United States | $0.086B | 11.30 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Hongchang (HCIL) | China | $0.052B | 0.00 |
| Biote (BTMD) | United States | $0.050B | 4.12 |
| Nephros (NEPH) | United States | $0.048B | 40.27 |
| Veru (VERU) | United States | $0.040B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.037B | 17.71 |
| United-Guardian (UG) | United States | $0.033B | 13.26 |
| Rockwell Medical (RMTI) | United States | $0.031B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.022B | 0.00 |
| Modular Medical (MODD) | United States | $0.021B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.019B | 0.00 |
| Bonk (BNKK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |